Neuropsychiatric Disease and Treatment

Antipsychotic Treatments - Transforming Schizophrenia Management in the Modern Era

We are pleased to announce a new Article Collection in Neuropsychiatric Disease and Treatment, dedicated to the game-changing role of antipsychotic treatments in the management of schizophrenia.

Since their clinical introduction, antipsychotic treatments have revolutionized care for patients with schizophrenia, offering benefits in reducing psychotic symptoms, stabilizing mood and emotions, improving cognitive and occupational functioning, and suicide prevention.

Given their global importance, Neuropsychiatric Disease and Treatment invites submissions of original research articles, reviews, and perspectives exploring the mechanisms of action, clinical efficacy, safety, and real-world application of antipsychotics in the management of schizophrenia.

The Collection, edited by the Editor-In-Chief Dr. Roger Pinder, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes.

While the call is open to receive manuscripts across the broad spectrum of antipsychotic treatment in schizophrenia, the Editors are particularly interested in manuscripts relating to the following areas, including but not limited to:

• Novel antipsychotic drug mechanisms, pharmacology, and targets
• Clinical effectiveness of antipsychotic drugs on reduction of psychotic symptoms and emotional regulation
• Impact of antipsychotic treatments on cognition, functional recovery, and neurobiological changes
• Efficacy and safety of antipsychotics for optimizing treatment and minimizing side effects
• Long-acting injectable (LAI) antipsychotic drugs for improving treatment adherence and patient outcomes
• Innovations and technologies in personalized antipsychotic treatment

Please submit your manuscript on our website and review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

Submitting authors will be eligible for a 20% discount of the Article Publishing Charge by applying the following code at the point of submission TQYVE. If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor Sam Zhang at sam.zhang@taylorandfrancis.com.

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.